Operating activities | |
Net loss | -54.76M |
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |
Depreciation and amortization | 31.29M |
Deferred income taxes | |
Impairment and loss on disposal of property, plant and equipment | |
Stock-based compensation expense | 6.42M |
Recoveries of bad debt | |
Write down for obsolete inventories | |
Changes in assets and liabilities, net of effects of acquisitions: | |
Accounts receivable | 14.13M |
Royalty income receivable | 2.18M |
Inventory, prepaid expenses and other assets | |
Income taxes receivable | |
Accounts payable and accrued expenses | -2.54M |
Deferred revenue and licensing fees | -3.85M |
Pension and postretirement benefits | -107K |
Other long-term liabilities | |
Net cash (used in) provided by operating activities | |
Investing activities | |
Purchases of investment securities | |
Proceeds from sales and maturities of investment securities | |
Purchase of business, net of cash acquired | -144.33M |
Purchase of property, plant and equipment | -37.95M |
Payments for patent applications and other costs | -188K |
Net cash provided by (used in) investing activities | |
Financing activities | |
Principal payments on long-term debt | -44.88M |
Purchase of treasury stock | -842K |
Proceeds from sale of common stock | 1.83M |
Tax benefit of stock based compensation | |
Net cash used in financing activities | |
Effect of exchange rate changes on cash flows | -48K |
Decrease in cash and cash equivalents | -4.59M |
Cash and cash equivalents at beginning of period | |
Cash and cash equivalents at end of period |